Obesity and thrombosis

被引:239
作者
Darvall, K. A. L.
Sam, R. C.
Silverman, S. H.
Bradbury, A. W.
Adam, D. J.
机构
[1] City Hosp, Dept Vasc Surg, Birmingham, W Midlands, England
[2] Univ Birmingham, Heartlands Hosp, Dept Vasc Surg, Birmingham B15 2TT, W Midlands, England
关键词
obesity; thrombosis; leptin; adiponectin; venous thromboembolism; metabolic syndrome;
D O I
10.1016/j.ejvs.2006.10.006
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives. To describe the pathophysiological mechanisms by which obesity increases the propensity to thrombosis, the leading cause of death in the Western World, with particular emphasis on the role of inflammation, oxidative stress, dyslipidaemia, insulin resistance and the coagulation cascade. Design. Review article. Materials and methods. Medline (1966-2005) and Cochrane library review of literature examining the relationship between obesity and thrombosis. Search terms included obesity, overweight, body mass index, thrombosis, cardiovascular disease, venous thromboembolism, peripheral arterial disease, and coronary heart disease. Results. Obesity is an important and growing public health issue that is estimated to affect more than half of the UK adult population. Obesity, in particular central (visceral) obesity, is associated with significant, and largely preventable, morbidity and mortality including an increased incidence and prevalence of arterial and venous thrombotic events. The various mechanisms by which obesity may cause thrombosis include: the actions of so-called adipocytokines from adipose tissue, e.g. leptin and adiponectin; increased activity of the coagulation cascade and decreased activity of the fibrinolytic cascade; increased inflammation; increased oxidative stress and endothelial dysfunction; and disturbances of lipids and glucose tolerance in association with the metabolic syndrome. Conclusions. Obesity appears to be associated with thrombosis via several mechanisms. These pro-thrombotic factors are all improved by weight loss.
引用
收藏
页码:223 / 233
页数:11
相关论文
共 97 条
  • [1] Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use
    Abdollahi, M
    Cushman, M
    Rosendaal, FR
    [J]. THROMBOSIS AND HAEMOSTASIS, 2003, 89 (03) : 493 - 498
  • [2] Ageno W, 2003, THROMB HAEMOSTASIS, V89, P305
  • [3] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [4] [Anonymous], 2001, AM J CARDIOL, DOI [DOI 10.1016/S0002-9149(01)01879-3, DOI 10.1016/S0002-9149(01)02145-2]
  • [5] [Anonymous], 2004, OB 3 REP SESS 2003 0
  • [6] Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METSGREECE Multicentre Study
    Athyros, VG
    Mikhailidis, DP
    Papageorgiou, AA
    Didangelos, TP
    Ganotakis, ES
    Symeonidis, AN
    Daskalopoulou, SS
    Kakafika, AI
    Elisaf, M
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (11) : 1691 - 1701
  • [7] Leptin
    Auwerx, J
    Staels, B
    [J]. LANCET, 1998, 351 (9104) : 737 - 742
  • [8] BAINTON D, 1994, BRIT HEART J, V72, P128
  • [9] Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo -: Evidence for a regulatory role of endothelin
    Barton, M
    Carmona, R
    Morawietz, HM
    d'Uscio, LV
    Goettsch, W
    Hillen, H
    Haudenschild, CC
    Krieger, JE
    Münter, K
    Lattmann, T
    Lüscher, TF
    Shaw, S
    [J]. HYPERTENSION, 2000, 35 (01) : 329 - 336
  • [10] Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898